Open Your Free Demat Account
Enjoy low brokerage on delivery trades
Prasol Chemicals Limited has been in the specialty chemicals business since 1996. Its portfolio of over 150 products — spanning acetone-based, phosphorous-based and other formulations — serves five end-use segments across domestic and international markets. The company operates in the specialty chemicals industry and serves customers across domestic and international markets through a diversified product portfolio.
Investors may note that a substantial portion of the issue consists of an Offer for Sale, with ₹420 crore going to selling shareholders and only ₹80 crore entering the company. Risks around raw material pricing, profit volatility, regulatory compliance and export exposure are worth examining carefully. Investors are advised to read the DRHP and all other publicly available documents before arriving at any investment decision on the proposed issue.
Specialty chemicals include hundreds of formulations used across pharmaceuticals, agrochemicals, paints, coatings, personal care, construction and other industries. Founded in 1996, Prasol Chemicals Limited manufactures over 150 specialty chemicals, serving diverse industries with a broad product portfolio.
The company filed its Draft Red Herring Prospectus (DRHP) with SEBI in October 2025, and received SEBI approval in March 2026. The DRHP covers the company's manufacturing operations, financial performance, customer base, growth approach and risk disclosures. The following sections summarise the key disclosures relating to the business, financial performance and proposed public issue.
The table below sets out the parameters of the proposed issue. Price band, lot size and issue dates have not yet been announced.
Particulars | Details |
IPO Type | Book Built Issue |
IPO Open Date | To be announced |
IPO Close Date | To be announced |
Face Value | ₹2 per equity share |
Price Band | To be announced |
Lot Size | To be announced |
Fresh Issue | Up to ₹80 crore |
Offer for Sale | Up to ₹420 crore |
Total Issue Size | Up to ₹500 crore |
Listing Exchange | NSE and BSE |
Registrar | Kfin Technologies Ltd. |
Book Running Lead Manager | Dam Capital Advisors Ltd. |
The issue has two components. The Fresh Issue of up to ₹80 crore brings funds directly into the company. The Offer for Sale of up to ₹420 crore involves shares being offloaded by existing selling shareholders — proceeds from that portion go to them, not the company. Final issue size, price band and dates will be confirmed closer to launch.
Prasol Chemicals traces its origins to April 1996, when it was incorporated as Prachi Poly Products Private Limited. Several corporate restructurings and name changes followed before the company arrived at its current identity. Its registered and corporate office is in Navi Mumbai, Maharashtra.
The promoters are Nishith Rajnikant Shah, Gaurang Natwarlal Parikh, Dhaval Nalin Parikh, Pankil Nishith Dharia, Sachin Jatin Parikh, Rakesh Gupta, Nishith Rasiklal Dharia, Kunal Tushar Dharia, Suketu Navinchandra Parikh and Usha Rajnikant Shah.
More than 150 specialty chemicals are manufactured by Prasol Chemicals across three categories:
Acetone-based chemicals — 21 products
Phosphorous-based chemicals — 53 products
Other specialty chemicals (surfactants, esters, acids and related formulations) — 76 products
Five end-use segments absorb these products:
Performance chemicals (lubricant and mining additives)
Paints, inks, construction and adhesives (PICA)
Pharmaceuticals
Agrochemicals
Home and personal care
The company operates across multiple product categories and serves customers in industries including performance chemicals, PICA, pharmaceuticals, agrochemicals, and home and personal care.
Prasol Chemicals generates revenue through the manufacture and sale of specialty chemicals supplied to customers across domestic and international markets. The company's product portfolio serves multiple industries, including performance chemicals, paints, inks, construction and adhesives (PICA), pharmaceuticals, agrochemicals, and home and personal care.
Revenue is derived from the sale of:
Acetone-based chemicals
Phosphorous-based chemicals
Surfactants
Esters
Acids
Other specialty chemical products
The company supplies its product portfolio to customers across multiple end-use industries in domestic and international markets.
Prasol Chemicals operates in India's specialty chemicals industry and has developed a diversified product portfolio comprising more than 150 specialty chemicals. The company serves customers across domestic and international markets and supplies products to a range of end-user industries, including pharmaceuticals, agrochemicals, performance chemicals, paints and coatings, and personal care.
According to the DRHP, the company had served 1,107 customers across 69 countries as of July 31, 2025. According to the DRHP, the company had served 1,107 customers across 69 countries as of July 31, 2025. It also holds Three Star Export House status issued by the Government of India. The company also holds Three Star Export House status issued by the Government of India.
Specialty chemicals are formulated for specific applications across industries such as pharmaceuticals, agrochemicals, paints, coatings, construction and personal care. Demand does not flow from a single source — pharmaceuticals, agriculture, personal care, industrial coatings and construction all consume specialty chemical inputs, each on its own cycle.
India's position in this market has strengthened over the past decade. Domestic manufacturing has expanded, pharmaceutical and agrochemical output has grown, and exports have risen as Indian producers move up the value chain. Import substitution trends have also supported opportunities for domestic specialty chemical manufacturers. These trends have supported the growth of the specialty chemicals industry in India over recent years.
The table below presents key financial figures from the DRHP on a restated consolidated basis.
Financials (₹ Crore) | FY2025 | FY2024 | FY2023 |
Total Income | 1,015.54 | 887.56 | 932.59 |
EBITDA | 87.77 | 60.53 | 86.95 |
Profit After Tax | 43.57 | 18.13 | 48.59 |
Total Assets | 723.09 | 626.36 | 692.54 |
Net Worth | 367.46 | 325.84 | 309.22 |
Total Borrowings | 101.05 | 82.07 | 185.63 |
1. Breadth of Product Portfolio
The company manufactures over 150 products across acetone-based, phosphorous-based and other specialty chemical categories, serving customers across multiple industries. The company's product portfolio covers multiple specialty chemical categories used across different industries.
2. Spread Across End-Use Industries
Pharmaceuticals, agrochemicals, paints, personal care and performance chemicals each contribute to demand. The company serves multiple end-use industries, including pharmaceuticals, agrochemicals, paints, personal care and performance chemicals.
3. Manufacturing Scale
The company operates two manufacturing facilities with a combined installed annual capacity of 87,914 MT.
4. Export Reach
According to the DRHP, the company had served 1,107 customers across 69 countries as of July 31, 2025. Three Star Export House status and distribution across four continents reflect an established global presence rather than opportunistic export sales.
5. Improving Balance Sheet
Total borrowings declined from ₹185.63 crore in FY2023 to ₹101.05 crore in FY2025. According to the DRHP, a part of the IPO proceeds is proposed to be used for repayment of borrowings.
6. R&D Pipeline
Product innovation is referenced in the DRHP as an ongoing focus, with new formulations under development. According to the DRHP, the company focuses on product development and research and development activities.
Specialty chemical manufacturing depends heavily on upstream chemical inputs. Price volatility or supply disruption in key raw materials — whether due to global commodity cycles, import dependencies or logistics constraints — can adversely affect margins and profitability.
The three-year financials show meaningful swings. PAT dropped from ₹48.59 crore in FY2023 to ₹18.13 crore in FY2024 — a decline of over 60%— before recovering. EBITDA moved in a similar direction. The company's EBITDA and PAT varied across the three reported financial years.
Of the ₹500 crore total issue size, ₹420 crore is an Offer for Sale. Only ₹80 crore comes into the company as fresh capital. Investors may note that a substantial portion of the issue consists of an Offer for Sale.
Domestic manufacturers and multinational chemical companies both compete in this space. In export markets, competition can affect both pricing and customer acquisition.
Chemical manufacturing is subject to environmental, safety and compliance oversight at multiple levels. A show-cause notice from the Department of Industrial Safety and Health (DISH) was referenced in the DRHP corrigendum dated January 2026, relating to a P2SS drum flaker and conveyor system at the Mahad facility. The company has stated that corrective measures have been implemented. Investors may review this disclosure and any updates in the final prospectus.
With customers across 69 countries, a portion of the business is subject to currency movement, trade policy changes, logistics costs and economic conditions in international markets. These factors can affect both revenue and margins from the export segment.
Those evaluating this issue may find it useful to examine:
Revenue and PAT trajectory across FY2023–FY2025, including the reasons behind the FY2024 dip
EBITDA margin trends and how they compare with specialty chemicals sector peers
The proportion of the issue represented by the Offer for Sale and the Fresh Issue
Debt reduction progress and the expected funded position post-IPO
Raw material sourcing — key inputs, supplier concentration and pricing exposure
Export versus domestic revenue mix and concentration within each
Customer concentration within the 1,107-customer base
The DISH show cause notice referenced in the January 2026 DRHP corrigendum
Competitive positioning within the specialty chemicals market
Risk factors and other disclosures in the DRHP
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading